The adenovirus E1A oncogene encodes two major proteins of 289 and 243 aa involved in cell immortalization, transformation in cooperation with ras, and transcriptional activation and repression on both viral and cellular genes. The E1A protein binds specifically to different gene products, including the tumor suppressor gene product of the retinoblastoma, a related 107 kDa protein, a 300 kDa polypeptide, and a 60 kDa cyclin a subunit of the cdc2 type kinase. Since E1A is by itself unable to bind DNA and no consensus activator or repressor site has been detected, we investigated interactions between E1A and cellular proteins required for transcription. We have thus described a novel interaction between adenovirus E1A and the cellular TATA-box binding protein TBP. A region close to the basic domain of TBP and the Zn finger domain are involved in this interaction. Moreover, we have established that ATF2, a cellular DNA binding protein also is able to interact with TBP, probably via a third protein. To establish the functional relevance of these interactions, we propose to perform in vitro and in vivo assays using E1A and TBP mutants, as well as ATF2 recombinants on several viral promoters. In vitro assays will focus on the rate, efficiency and stability of transcription complex formation and transcription stimulation. In vivo assays will either alter the levels of these basal components or assay transdominance effects (i.e., E1A or TBP mutants which interfere with normal transactivation) in promoters that have been shown to respond to E1A via the TATA-box sequence. We will use protein-protein screening of expression libraries to look for additional sequences encoding proteins which may be, at least in part, responsible for the pleiotropic effects of the E1A oncogene. The role of these proteins in normal cellular processes in the absence of E1A will also be determined. These experiments will clarify the mechanism by which E1A stimulates or represses transcription, an important part of its oncogenic potential.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044466-09
Application #
2007626
Study Section
Experimental Virology Study Section (EVR)
Project Start
1988-03-01
Project End
1997-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Princeton University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
002484665
City
Princeton
State
NJ
Country
United States
Zip Code
08544
Sang, N; Claudio, P P; Fu, Y et al. (1997) Transforming region of 243R E1A contains two overlapping but distinct transactivation domains. DNA Cell Biol 16:1321-33
Lewis, B A; Tullis, G; Seto, E et al. (1995) Adenovirus E1A proteins interact with the cellular YY1 transcription factor. J Virol 69:1628-36
Horikoshi, N; Usheva, A; Chen, J et al. (1995) Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol Cell Biol 15:227-34
Beck, I; Weinmann, R; Caro, J (1993) Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82:704-11
Ge, R; Kralli, A; Weinmann, R et al. (1992) Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding. J Virol 66:6969-78
Maguire, K; Shi, X P; Horikoshi, N et al. (1991) Interactions between adenovirus E1A and members of the AP-1 family of cellular transcription factors. Oncogene 6:1417-22
Bagchi, S; Weinmann, R; Raychaudhuri, P (1991) The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65:1063-72
Horikoshi, N; Maguire, K; Kralli, A et al. (1991) Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. Proc Natl Acad Sci U S A 88:5124-8
Caceres, J; Glikin, G; Bravo, R et al. (1990) c-fos mediated stimulation of an AP-1 DNA binding activity in undifferentiated teratocarcinoma cell lines. Oncogene 5:59-67